People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
NEW YORK: The blue-chip Dow rose on Friday to hit an intraday record and small-cap stocks outperformed after a benign ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The ...